ADA-deficient mice are characterized by chronically enhanced tissue adenosine levels and collagen content as well as increased levels of pro-fibrotic mediators like TGF-β, α-SMA, CTGF and IL-13, and are therefore used as paradigm of adenosine-induced fibrosis in the lung and the skin. The gene discussed is ADA; the disease is fibrosis.